180 related articles for article (PubMed ID: 29808798)
1. Knockdown of SIRT1 inhibits proliferation and promotes apoptosis of paclitaxel-resistant human cervical cancer cells.
Xia X; Zhou X
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):36-41. PubMed ID: 29808798
[TBL] [Abstract][Full Text] [Related]
2. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057
[TBL] [Abstract][Full Text] [Related]
3. CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR-665-dependent regulation of EGFR.
Dong M; Li P; Xie Y; Wang Z; Wang R
Drug Dev Res; 2021 Dec; 82(8):1193-1205. PubMed ID: 34046939
[TBL] [Abstract][Full Text] [Related]
4. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
[TBL] [Abstract][Full Text] [Related]
7. Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin.
Kobayashi Y; Seino K; Hosonuma S; Ohara T; Itamochi H; Isonishi S; Kita T; Wada H; Kojo S; Kiguchi K
Gynecol Oncol; 2011 May; 121(2):390-4. PubMed ID: 21272926
[TBL] [Abstract][Full Text] [Related]
8. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 promotes the proliferation and metastasis of human pancreatic cancer cells.
Jin J; Chu Z; Ma P; Meng Y; Yang Y
Tumour Biol; 2017 Mar; 39(3):1010428317691180. PubMed ID: 28351313
[TBL] [Abstract][Full Text] [Related]
10. circ_ZFR Is Linked to Paclitaxel Resistance in Cervical Cancer via miR-944 Sponging and IL-10 Upregulation.
Long X; Zheng M; Yang Y; Chen Y; Zhang X; Zhang H
Anal Cell Pathol (Amst); 2022; 2022():4807287. PubMed ID: 35127342
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 promotes proliferation, migration, and invasion of breast cancer cell line MCF-7 by upregulating DNA polymerase delta1 (POLD1).
Xu Y; Qin Q; Chen R; Wei C; Mo Q
Biochem Biophys Res Commun; 2018 Jul; 502(3):351-357. PubMed ID: 29807012
[TBL] [Abstract][Full Text] [Related]
12. Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB.
Kaewpiboon C; Srisuttee R; Malilas W; Moon J; Kaowinn S; Cho IR; Johnston RN; Assavalapsakul W; Chung YH
Oncol Rep; 2014 Jan; 31(1):161-8. PubMed ID: 24220725
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line.
Fu L; Yin F; Li XR; Han BK; Zhang C; Wang JW; Wang YQ; Bi YF; Liu HM
Anticancer Drugs; 2018 Jul; 29(6):491-502. PubMed ID: 29683800
[TBL] [Abstract][Full Text] [Related]
14. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel.
Feng W; Xiaoyan X; Xuan Y; Xiangke L; Zichang Y; Ran Z; Liuxing W; Qingxia F
Cancer Gene Ther; 2015 Apr; 22(3):115-21. PubMed ID: 25572118
[TBL] [Abstract][Full Text] [Related]
15. Guanylate-binding protein-2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel-resistant colorectal cancer cells by interfering Wnt signaling.
Wang J; Min H; Hu B; Xue X; Liu Y
J Cell Biochem; 2020 Feb; 121(2):1250-1259. PubMed ID: 31489998
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy.
Wang Y; Shen F; Zhou J; Fang Y; Qi Y; Chen Y
Drug Dev Res; 2022 Feb; 83(1):142-149. PubMed ID: 34189759
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg5 Sensitizes Paclitaxel-Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel-And Enhances the Anticancer Effect of Paclitaxel.
Ramesh J; Thilakan RC; Gopalakrishnan RM; Vijayapoopathi S; Dorschel A; Venugopal B
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885925
[TBL] [Abstract][Full Text] [Related]
18. HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma.
Peng J; Zhao J; Zhao Y; Wu P; Gou L; Fu S; Chen P; Lu Y; Yang L
Int J Nanomedicine; 2020; 15():6409-6420. PubMed ID: 32922008
[TBL] [Abstract][Full Text] [Related]
19. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
[TBL] [Abstract][Full Text] [Related]
20. Clusterin confers paclitaxel resistance in cervical cancer.
Park DC; Yeo SG; Shin EY; Mok SC; Kim DH
Gynecol Oncol; 2006 Dec; 103(3):996-1000. PubMed ID: 16890274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
